Atalan Capital Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$82.7M Buy
915,270
+31,600
+4% +$2.68M 5.07% 9
2026
Q1
$73.8M Sell
883,670
-31,480
-3% -$2.58M 6.81% 8
2025
Q4
$83.8M Buy
915,150
+3,550
+0.4% +$340K 5.97% 11
2025
Q3
$86.4M Buy
911,600
+211,600
+30% +$19.9M 6.03% 10
2025
Q2
$73.3M Buy
+700,000
New +$66.4M 5.63% 8

Other funds holding HQY

Atalan Capital Partners's HQY Position: Q2 2026 in Review

Atalan Capital Partners increased its HealthEquity (HQY) stake by 3.6% in Q2 2026, buying an estimated $2.68M and bringing the position to 915,270 shares worth $82.7M. The position accounts for 5.07% of the portfolio, ranked #9.

Atalan Capital Partners first reported a position in HQY in Q2 2025 and has held it in 5 quarters since. The position peaked at $86.4M in Q3 2025. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Atalan Capital Partners held 915,270 shares of HealthEquity worth $82.7M as of Q2 2026.
  • Atalan Capital Partners bought 31,600 HealthEquity shares in Q2 2026, an estimated $2.68M.
  • HealthEquity made up 5.07% of Atalan Capital Partners's portfolio in Q2 2026, its #9 holding.
  • Atalan Capital Partners first reported a position in HealthEquity in Q2 2025 and has held it in 5 quarters since.
  • Atalan Capital Partners's HealthEquity position peaked at $86.4M in Q3 2025.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Atalan Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.